Rajeev M. Shah, Director at Mineralys Therapeutics, Inc. (MLYS), bought 369,000 shares at $23.67 ($8.8M) on 2026-03-27, disclosed to the SEC on 2026-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.67 | 310,700 | $7.4M | 83.9% |
| 2 | $24.16 | 58,300 | $1.4M | 16.1% |
| Total | $23.75 avg | 369,000 | $8.8M | 100% |
| Filing → |
| AVTE | BUY | 2024-06-20 | $3.1M | — | Filing → |
| HOWL | BUY | 2023-01-10 | $4.1M | — | Filing → |
| IMRA | BUY | 2022-12-12 | $191K | — | Filing → |